Luca Bertamini - Dissemin

All papers authored by Luca Bertamini

This paper was not found in any repository, but could be made available legally by the author.

2023 Roberto Mina

, Pellegrino Musto

, Delia Rota-Scalabrini

, Laura Paris

, Barbara Gamberi

, Angelo Palmas

, Sara Aquino

, Paolo de Fabritiis

, Nicola Giuliani

, Luca De Rosa

, Alessandro Gozzetti

, Claudia Cellini

, Luca Bertamini

, Andrea Capra

, Daniela Oddolo

and 12 other authors

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

Upload

This paper is made freely available by the publisher.

2022 Luca Bertamini

, Stefania Oliva

, Delia Rota-Scalabrini

, Laura Paris

, Sonia Morè, Paolo Corradini

, Antonio Ledda, Massimo Gentile

, Giovanni De Sabbata

, Giuseppe Pietrantuono, Anna Pascarella

, Patrizia Tosi

, Paola Curci

, Milena Gilestro, Andrea Capra and 14 other authors

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

Download from doi.org

Luca Bertamini

, Giuseppe Bertuglia

, Stefania Oliva

Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World Results

Download from doi.org

2021 Francesca Gay, Pellegrino Musto, Delia Rota-Scalabrini, Luca Bertamini

, Angelo Belotti, Monica Galli, Massimo Offidani, Elena Zamagni

, Antonio Ledda, Mariella Grasso, Stelvio Ballanti, Antonio Spadano, Michele Cea, Francesca Patriarca, Mattia D'Agostino and 11 other authors

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

Upload

Nitya Nathwani, Luca Bertamini

, Rahul Banerjee, Francesca Gay, Nina Shah, Amrita Krishnan

When and How to Treat Relapsed Multiple Myeloma

Download from doi.org

Francesca Gay, Roberto Mina, Delia Rota-Scalabrini, Monica Galli, Angelo Belotti, Elena Zamagni, Luca Bertamini

, Renato Zambello, Barbara Gamberi, Giovanni De Sabbata, Giuseppe Pietrantuono, Andrea Capra, Anna Pascarella, Anna Marina Liberati, Salvatore Palmieri and 5 other authors

Carfilzomib-based induction/consolidation with or without autologous transplant (ASCT) followed by lenalidomide (R) or carfilzomib-lenalidomide (KR) maintenance: Efficacy in high-risk patients.

Download from doi.org

Luciano Xumerle, Paolo Garagnani

, Julien Marquis, Massimo Delledonne, Chiara Pirazzini, Frederic Raymond, Elena Marasco, Alberto Ferrarini, Katarzyna Malgorzata Kwiatkowska

, Sebastiano Collino, Daniela Mari, Beatrice Arosio, Vincenzo Iannuzzi, Martina Casati, Evelyn Ferri and 21 other authors

Whole-genome sequencing analysis of semi-supercentenarians

Download from doi.org

Gian Maria Zaccaria

, Luca Bertamini

, Maria Teresa Petrucci, Massimo Offidani, Paolo Corradini, Andrea Capra, Alessandra Romano, Anna Marina Liberati

, Donato Mannina, Paolo de Fabritiis, Nicola Cascavilla

, Marina Ruggeri, Roberto Mina, Francesca Patriarca, Giulia Benevolo

and 9 other authors

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients

Upload

Luca Bertamini

, Mattia D’Agostino, Francesca Gay

MRD Assessment in Multiple Myeloma: Progress and Challenges

Download from link.springer.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

L. Bertamini

, P. Stefanoni, P. Tacchetti, A. Ledda, A. Palmas, M. Gentile, S. Palmieri, O. Annibali, C. Musolino, M. Burdisso

High Levels of Circulating Plasma Cells Are an Independent High-Risk Feature in Multiple Myeloma Patients and Their Prognostic Impact Is Modulated by the Achievement of Minimal Residual Disease Negativity

Upload

Francesca Gay, Pellegrino Musto, Delia Rota-Scalabrini, Luca Bertamini

, Angelo Belotti, Monica Galli, Massimo Offidani, Elena Zamagni, Antonio Ledda, Mariella Grasso, Stelvio Ballanti, Antonio Spadano, Michele Cea, Francesca Patriarca, Mattia D'Agostino and 11 other authors

Upload

2020 Giovanni Marconi

, Stefano De Polo, Giovanni Martinelli, Jacopo Nanni, Luca Bertamini

, Annalisa Talami, Matteo Olivi, Emanuela Ottaviani, Simone Ragaini, Nicoletta Testoni, Maria Teresa Bochicchio, Maria Chiara Abbenante, Sarah Parisi, Maria Chiara Fontana, Chiara Sartor and 8 other authors

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients

Upload

Distributing this paper is prohibited by the publisher

Luca Bertamini

, Mariella Grasso, Mattia D'Agostino, Anna Pascarella, Patrizia Tosi, Federico Monaco, Francesco Pisani, Paola Bertazzoni, Milena Gilestro, Andrea Capra, Piero Galieni, Ombretta Annibali, Vincenzo Pavone, Stefano Molica, Sonia Ronconi and 5 other authors

Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity

Upload

Francesca Gay, Pellegrino Musto, Delia Rota Scalabrini, Monica Galli, Angelo Belotti, Elena Zamagni, Luca Bertamini

, Renato Zambello, Micol Quaresima, Giovanni De Sabbata, Giuseppe Pietrantuono, Mattia D'Agostino, Daniela Oddolo, Andrea Capra, Anna Marina Liberati and 5 other authors

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

Upload

Luca Bertamini

, Francesca Gay

Checkpoint inhibitors and myeloma: promises, deadlocks and new directions

Upload

Luca Bertamini

, Francesca Bonello, Mario Boccadoro, Sara Bringhen

New drugs in early development for treating multiple myeloma: all that glitters is not gold

Upload

Giovanni Marconi

, Annalisa Talami, Maria Chiara Abbenante, Chiara Sartor, Sarah Parisi, Jacopo Nanni, Luca Bertamini

, Gianluca Cristiano, Maria Chiara Fontana, Simone Ragaini, Maria Teresa Bochicchio

, Matteo Olivi, Emanuela Ottaviani, Mario Arpinati, Stefano de Polo and 11 other authors

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia

Upload

2019 Mattia D'Agostino, Luca Bertamini

, Stefania Oliva

, Mario Boccadoro, Francesca Gay

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies

Download from doi.org

Francesca Gay, Gian Maria Zaccaria

, Massimo Offidani, Federico Vozella, Paolo Becco, Angelo Belotti, Andrea Capra, Monica Galli, Fortunato Morabito, Luca Bertamini

, Francesco Pisani, Piero Galieni, Rita Rizzi, Alessandro Gozzetti

, Norbert Pescosta and 10 other authors

Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients

Upload

Francesca Bonello, Giusy Cetani, Luca Bertamini

, Francesca Gay, Alessandra Larocca

Moving Toward Continuous Therapy in Multiple Myeloma

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Luca Bertamini